These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Magnetic albumin/protein A immunomicrospheres. I. Preparation, antibody binding capacity and chemical stability. Kandzia J; Scholz W; Anderson MJ; Müller-Ruchholtz W J Immunol Methods; 1984 Dec; 75(1):31-41. PubMed ID: 6392424 [TBL] [Abstract][Full Text] [Related]
45. Specific cell binding using staphylococcal protein A magnetic microspheres. Widder KJ; Senyei AE; Ovadia H; Paterson PY J Pharm Sci; 1981 Apr; 70(4):387-9. PubMed ID: 7229948 [TBL] [Abstract][Full Text] [Related]
46. Magnetic microspheres: synthesis of a novel parenteral drug carrier. Widder K; Flouret G; Senyei A J Pharm Sci; 1979 Jan; 68(1):79-82. PubMed ID: 569198 [TBL] [Abstract][Full Text] [Related]
47. Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents. Widder KJ; Senyei AE; Ranney DF Adv Pharmacol Chemother; 1979; 16():213-71. PubMed ID: 382799 [No Abstract] [Full Text] [Related]
48. A single-blind, parallel trial of L-hydroxyproline in healthy adult subjects. Akiduki S; Ito H; Morishita K; Kamimura A Urolithiasis; 2015 Jun; 43(3):289-92. PubMed ID: 25827754 [No Abstract] [Full Text] [Related]
49. Targeted delivery of low dose doxorubicin hydrochloride administered via magnetic albumin microspheres in rats. Gupta PK; Hung CT J Microencapsul; 1990; 7(1):85-94. PubMed ID: 2308056 [TBL] [Abstract][Full Text] [Related]
50. Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats. Widder KJ; Morris RM; Poore GA; Howard DP; Senyei AE Eur J Cancer Clin Oncol; 1983 Jan; 19(1):135-9. PubMed ID: 6682771 [TBL] [Abstract][Full Text] [Related]
51. Topical high molecular weight hyaluronan reduces radicular pain post laminectomy in a rat model. Massie JB; Schimizzi AL; Huang B; Kim CW; Garfin SR; Akeson WH Spine J; 2005; 5(5):494-502. PubMed ID: 16153575 [TBL] [Abstract][Full Text] [Related]
52. cis-Hydroxyproline inhibits proliferation, collagen synthesis, attachment, and migration of cultured bovine retinal pigment epithelial cells. Yoo JS; Sakamoto T; Spee C; Kimura H; Harris MS; Hinton DR; Kay EP; Ryan SJ Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):520-8. PubMed ID: 9040485 [TBL] [Abstract][Full Text] [Related]
53. Synthesis and characterization of magnetically responsive albumin microspheres containing cis-hydroxyproline for scar inhibition. Iannotti JP; Baradet TC; Tobin M; Alavi A; Staum M J Orthop Res; 1991 May; 9(3):432-44. PubMed ID: 2010848 [TBL] [Abstract][Full Text] [Related]
54. Prevention of collagen deposition following pulmonary oxygen toxicity in the rat by cis-4-hydroxy-L-proline. Riley DJ; Berg RA; Edelman NH; Prockop DJ J Clin Invest; 1980 Mar; 65(3):643-51. PubMed ID: 6986411 [TBL] [Abstract][Full Text] [Related]